Institutional members access full text with Ovid®

Share this article on:

Need for rescue therapy in IBD patients on infliximab maintenance therapy after discontinuation of immunomodulator: O-0003.

Fischer, M; Helper, D; Chiorean, M; Juliar, B

Oral Abstracts - Clinical

Indiana University, Indianapolis, IN, USA

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website